ArticleCardiology2022

Are Post Hoc Analyses on Subgroups Sufficient to Support New Treatment Algorithms of Heart Failure? The Case of SGLT2 Inhibitors Associated with Sacubitril/Valsartan.

Massimo Volpe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.